Preventing and Minimizing Risks Associated with Antituberculosis Medicines to Improve Patient Safety

by Chinwe Owunna, Chinedum Abanobi and Jude Nwokike
Systems for Improved Access to Pharmaceuticals and Services, December 2013

92 pp. 3.5 MB:
http://siapsprogram.org/wp-content/uploads/2014/02/14-033-Min-Risk-Anti-TB-Meds-final.pdf

Successfully combating the TB epidemic requires expanding access to treatment, improving management of drug-resistant TB, and integrating services for TB and HIV. To help patients complete their full course of TB treatment, the United States Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program created a guide for national tuberculosis programs (NTP) on how to minimize medicine risks. The guide offers insights into planning and implementing risk reduction strategies in the treatment of TB.

(Visited 56 times, 1 visits today)
This entry was posted in Essential Medicines, General, Tuberculosis. Bookmark the permalink.